hoxa9 expression

MI-2-2 is an inhibitor of bivalent protein-protein interaction between menin and MLL with an IC50 of 46 nM. MI-2-2 binds to menin with Kd of 22 nM.

Menin-MLL inhibitor MI-2 dihydrochloride is a competitive and selective inhibitor of the Menin-MLL interaction, with an IC50 value of 446 nM and a Ki value of 158 nM. It reduces the expression of target genes such as HOXA9 and MEIS1, inhibits the proliferation of leukemic cells, and induces apoptosis and differentiation. Menin-MLL inhibitor MI-2 dihydrochloride shows potential for research in MLL-rearranged acute leukemias, such as acute myeloid leukemia and acute lymphoblastic leukemia.

EPZ004777 formate is an effective and selective DOT1L inhibitor with an IC50 of 0.4 nM. It reduces levels of H3K79me2 and H3K79me1, significantly downregulating the expression of HOXA9 and MEIS1. This compound selectively inhibits the proliferation of MLL-rearranged cells and induces differentiation followed by apoptosis in leukemia cells, making it useful for leukemia research.